CLINICAL_TRIALS
trial_result
· 2014-03-03
Clinical Trial Update: Exploratory Study of Plaque Regression [Phase 2]
Summary
A Phase 2 exploratory trial evaluating plaque regression in patients with heterozygous familial hypercholesterolemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cerenis Therapeutics, SA | Conditions: Heterozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED